BioXcel Therapeutics, Inc. (BTAI) Operating margin 2022–2025
BioXcel Therapeutics, Inc. (BTAI) operating margin by fiscal year — reported operating income divided by reported revenue.
-7860.0%FY2025 · since FY2022: -42572.0% → -7860.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7860.0% | -4892.4 pp |
| FY2024 | -2967.6% | +9480.4 pp |
| FY2023 | -12448.0% | +30124.0 pp |
| FY2022 | -42572.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice